Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

1.0K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

479
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
479
Hepatitis01:25

Hepatitis

34
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
34
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

620
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
620
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.3K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.3K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

633
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
633

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Navigating the landscape of liver transplantation in neuroendocrine tumors: A comprehensive scoping review.

World journal of transplantation·2026
Same author

Impaired Iron-Copper Metabolic Axis in Human Intestinal Mucosa After Roux-en-Y Gastric Bypass: A Prospective Transcriptomic Study Using Double-Balloon Enteroscopy.

Obesity surgery·2026
Same author

Anesthetic challenges of the first successful living-donor uterus transplantation in Latin America: a case report.

Clinics (Sao Paulo, Brazil)·2026
Same author

Preoperative plasma miR-144-3p to predict persistent type 2 diabetes after gastric bypass - a pilot proof-of-concept study.

Diabetes research and clinical practice·2025
Same author

Growth and rupture of pancreatic mucinous cystic neoplasm following hormonal stimulation for <i>in vitro</i> fertilization: a case report.

Journal of surgical case reports·2025
Same author

Changes in Plasma Sphingolipid Metabolites Following Roux-En-Y Gastric Bypass in Women With Obesity and Type 2 Diabetes: A Pilot Metabolomic Cohort Study.

Lipids·2025

Related Experiment Video

Updated: Mar 28, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

11.2K

NUTRITIONAL SUPPORT FOR FULMINANT HEPATITIS.

Estela Regina Ramos Figueira1, Joel Avancini Rocha Filho2, Lucas Souto Nacif3

  • 1Hospital das Clínicas from University of Sao Paulo School of Medicine, Discipline of Digestive Surgery and LIM37, Department of Gastroenterology, Sao Paulo.. estelafigueira@me.com.

Nutricion Hospitalaria
|December 16, 2015
PubMed
Summary
This summary is machine-generated.

Nutritional support is vital for fulminant hepatitis (FH) patients, addressing metabolic issues like hyperammonemia. Individualized nutrition, including specific energy and protein targets, can improve outcomes and reduce mortality in FH.

More Related Videos

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.5K
Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
09:27

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Published on: April 1, 2021

4.1K

Related Experiment Videos

Last Updated: Mar 28, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

11.2K
The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.5K
Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
09:27

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Published on: April 1, 2021

4.1K

Area of Science:

  • Hepatology
  • Clinical Nutrition
  • Critical Care Medicine

Background:

  • Fulminant hepatitis (FH) involves severe metabolic disturbances, including hypercatabolism, hypoglycemia, and hyperammonemia.
  • Proinflammatory cytokines and catabolic hormones exacerbate the patient's condition in FH.
  • Effective nutritional support is critical for patient recovery in FH.

Purpose of the Study:

  • To provide an updated review on nutritional support strategies for patients with fulminant hepatitis.
  • To consolidate current knowledge on managing metabolic derangements through nutrition in FH.

Main Methods:

  • A comprehensive literature review was conducted.
  • Searches were performed on Medline-PubMed using Medical Subject Headings (MeSH) terms.

Main Results:

  • Limited data exists on nutritional support for FH and acute liver failure.
  • Initial nutritional interventions should target metabolic derangements and be individualized.
  • Recommended energy intake is 25–40 kcal/kg/day, and protein intake is 0.8–1.2 g/kg/day.
  • Enteral nutrition is advised for patients with encephalopathy or oral feeding difficulties.
  • Lipid administration should be cautious, and protein intake can utilize BCAA-based formulas.

Conclusions:

  • Individualized nutritional strategies are essential for managing FH.
  • Adequate nutrition therapy holds the potential to decrease morbidity and mortality in FH patients.